Historical review traces cannabis use for gut problems from ancient medicine to modern science
Cannabis has been used for gastrointestinal symptoms across cultures for millennia, and modern research on the endocannabinoid system provides biological rationale for its anti-inflammatory and motility-enhancing effects in the gut.
Quick Facts
What This Study Found
Historical records from multiple cultures document cannabis use for nausea, vomiting, diarrhea, and inflammatory bowel conditions. Modern research confirms endocannabinoid system involvement in gut function, with THC:CBD preparations showing promise for inflammation and motility.
Key Numbers
Reviews evidence from multiple cultural traditions spanning thousands of years. Discusses the endocannabinoidome as an expanded system beyond classical endocannabinoid signaling in gastrointestinal modulation.
How They Did This
Narrative review combining ethnomedicinal history of cannabis for gastrointestinal conditions with modern pharmacological understanding of the endocannabinoid system and expanded endocannabinoidome in gut function.
Why This Research Matters
Understanding the historical use of cannabis for gut conditions provides context for modern research directions and highlights that this is not a new therapeutic concept but one that was interrupted by prohibition.
The Bigger Picture
The 1937 Marijuana Tax Act effectively halted cannabis research for decades. Reconnecting historical use with modern molecular understanding of the endocannabinoid system could accelerate development of cannabinoid-based gastrointestinal therapies.
What This Study Doesn't Tell Us
Narrative review without systematic methodology. Historical accounts lack the rigor of modern clinical evidence. Modern evidence for cannabinoids in GI conditions remains primarily preclinical. Optimal formulations and dosing for GI conditions are unknown.
Questions This Raises
- ?Which specific gastrointestinal conditions are most likely to benefit from cannabinoid therapies?
- ?Can the expanded endocannabinoidome be targeted more precisely than whole-plant cannabis?
Trust & Context
- Key Stat:
- Cannabis used for GI symptoms across cultures for millennia; endocannabinoid system now provides biological basis
- Evidence Grade:
- Narrative review combining historical accounts with modern pharmacology. Provides context but not clinical evidence.
- Study Age:
- Published 2023.
- Original Title:
- Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.
- Published In:
- International journal of molecular sciences, 24(19) (2023)
- Authors:
- Thapa, Dinesh(5), Warne, Leon N(5), Falasca, Marco(4)
- Database ID:
- RTHC-04979
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Has cannabis always been used for stomach problems?
Yes. Historical records from numerous cultures document cannabis use for nausea, vomiting, diarrhea, and abdominal pain. These traditional uses were disrupted by global cannabis prohibition in the 20th century but are now being revisited through the lens of modern pharmacology.
How does the endocannabinoid system affect the gut?
The endocannabinoid system is active throughout the gastrointestinal tract, influencing motility, inflammation, pain signaling, and secretion. Cannabinoid receptors (CB1 and CB2) are present in gut tissue, and the expanded endocannabinoidome includes additional lipid mediators that modulate digestive function.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04979APA
Thapa, Dinesh; Warne, Leon N; Falasca, Marco. (2023). Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.. International journal of molecular sciences, 24(19). https://doi.org/10.3390/ijms241914677
MLA
Thapa, Dinesh, et al. "Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.." International journal of molecular sciences, 2023. https://doi.org/10.3390/ijms241914677
RethinkTHC
RethinkTHC Research Database. "Pharmacohistory of Cannabis Use-A New Possibility in Future ..." RTHC-04979. Retrieved from https://rethinkthc.com/research/thapa-2023-pharmacohistory-of-cannabis-usea
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.